Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Avigen and Bayer collaborate to bring Coagulin-B to market

Nov. 24, 2000

ACUTE II results presented at AHA sessions

Nov. 23, 2000

Baxter's new recombinant hemophilia therapy enters phase III

Nov. 23, 2000

FDA approves Lovenox for seventh indication

Nov. 22, 2000

S-18886 improves endothelial function in CAD patients

Nov. 21, 2000

Direct factor Xa inhibitor FXV-673 shows good results versus heparin

Nov. 21, 2000

Novel thrombin inhibitor prodrugs for oral administration

Nov. 20, 2000

Genzyme Transgenics reacquires rights to rhATIII

Nov. 17, 2000

SmithKline Beecham launches Argatroban in U.S.

Nov. 15, 2000

Soluble CD39: ex vivo dose-response evaluation in combination with known antiplatelet agents

Nov. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...